A Kaiser Permanente study finds COVID-19 patients treated quickly with Paxlovid have a 90% lower risk of hospitalization and death PASADENA, Calif., March 16, 2023 /PRNewswire/ — A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an…
